Evidence map›Paper›PMID 38256448›Full record

ArticleJournal of clinical medicine2024

Central American and Caribbean Consensus Document for the Optimal Management of Oral Anticoagulation in Patients with Non-Valvular Atrial Fibrillation Endorsed by the Central American and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention.

Fernando Wyss, Vivencio Barrios, Máxima Méndez, Samuel Ramos, Ángel Gonzalez, Héctor Ortiz, Marco Rodas Díaz, Gabriela Castillo, Daniel Quesada, Carlos Enrique Franco and 7 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 8 countries.

Fernando WyssCardiovascular Services and Technology of Guatemala, CARDIOSOLUTIONS, Central American and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention, Guatemala City 01010, Guatemala.
Vivencio BarriosCardiology Department, University Hospital Ramon y Cajal, School of Medicine, Alcala University, 28034 Madrid, Spain.ORCID 0000-0001-6135-7685
Máxima MéndezCardiologist-Internal Medicine, Medicine Autonomous University, Santo Domingo 10105, Dominican Republic.ORCID 0000-0002-9651-916X
Samuel RamosCardiology Department, Presidente Estrella Ureña Hospital, Santiago de los Caballeros, Salvador B. Gautier Hospital, Santo Domingo 10514, Dominican Republic.
Ángel GonzalezCardiology Department, Hospiten Santo Domingo, Autónoma de Santo Domingo University, Santo Domingo 1355, Dominican Republic.
Héctor OrtizCardiology Department, Herrera Llerandi Hospital, Guatemala City 01010, Guatemala.
Marco Rodas DíazGuatemalan Association of Cardiology, Cardiovascular Surgery Unit of Guatemala (UNICAR), Guatemala City 01010, Guatemala.
Gabriela CastilloCardiology Department, Max Peralta Hospital, Costa Rica University Cartago, Cartago 30101, Costa Rica.
Daniel QuesadaCardiology Department, Hospital San Vicente de Paul, Universidad de Costa Rica, Heredia 40101, Costa Rica.ORCID 0000-0003-4367-549X
Carlos Enrique FrancoCardiology Department, Surgical and Oncological Medical Hospital, Instituto Salvadoreño del Seguro Social, Escalon Medical Center, San Salvador 1101, El Salvador.
Jaime VenturaCardiology Department, Instituto Salvadoreño del Seguro Social, San Salvador 1101, El Salvador.
Emilio Peralta LópezCardiology Department, Instituto Nacional Cardiopulmonar, Tegucigalpa 11101, Honduras.
Francisco SomozaCardiology Department, CEMESA Hospital, San Pedro Sula 21102, Honduras.
Ariel Arguello MontealegreCardiology Department, Vivían Pellas Hospital, Managua 11044, Nicaragua.
Daniel MenesesCardiology Department, Del Valle Cardiologic Clinique, Nacional Autónoma of Nicaragua University, Managua 14145, Nicaragua.
Daniel PichelCardiology Department, Paitilla Hospital, University of Panamá, Paitilla 06001, Panama.
Osiris ValdezAmerican and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention, Guatemala City 01010, Guatemala.
Unidad de Cirugía Cardiovascular de Guatemala · GTUniversidad Autónoma de Santo Domingo · DOHonduras Foundation for Agricultural Research · HNNational Autonomous University of Nicaragua · NIUniversidad de Alcalá · ESUniversidad de Costa Rica · CRUniversidad de Panamá · PAUniversity of El Salvador · SV

Funding

Mefasa Farma (Grupo Profarmaco) Mefasa Farma (Grupo Profarmaco)
6 · The paper itself

Abstract

Atrial fibrillation (AF) is the most common arrhythmia in adults. Prevention of the ischaemic risk with oral anticoagulants (OACs) is widely recommended, and current clinical guidelines recommend direct oral anticoagulants (DOACs) as preference therapy for stroke prevention. However, there are currently no clinical practice guidelines or recommendation documents on the optimal management of OACs in patients with AF that specifically address and adapt to the Central American and Caribbean context. The aim of this

Indexed as

accessanticoagulationatrial fibrillationCentral American and Caribbeandirect oral anticoagulantsVitamin K antagonists

Identifiers

PMID38256448
PMCPMC10816126
OpenAlexW4390617918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.